11
Cancer Diagnostics 2017 conferenceseries.com http://cancerdiagnostics.conferenceseries.com/ ***For available speaker slots *** [email protected] Tentative Program 2 nd Cancer Diagnostics Conference & Expo May 8-10, 2017 Barcelona, Spain Interactive Sessions Keynote Lectures Exhibitors B2B Meetings Plenary Lectures Workshops

Cancer diagnostics 2017

Embed Size (px)

Citation preview

Page 2: Cancer diagnostics 2017

Cancer Diagnostics 2017conferenceseries.com

http://cancerdiagnostics.conferenceseries.com/

Reception/Registration Time

09.00-09.1509.15-09.4509.45-10.1510.15-10.45

Time Session 1 Session 25 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)

Time Session 1 Session 25 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)Awards and Closing Ceremony

Day 1

10.55-12.35

13.25-15.05

Inaugural AddressKeynote/Plenary Talk 1Keynote/Plenary Talk 2Keynote/Plenary Talk 3

Keynote speaker slots are available

15.45-17.25

6 Speakers (20 Mins Each)

Program at A Glance

08.00-09.00

Mor

ning

Ses

sion

s

5 speaker (20 mins each)11.00-12.40

19 sp

eake

r for

day

1

Coffee/Tea Break 10.45-11.00 (Networking)

Least of 3 Keynote/Plenary Talks

Speaker slots are available

Lunch Break 12.40-13.30

Even

ing

Sess

ions

Panel Discussions/Group Photo

Coffee/Tea Break 15.30-15.45 (Networking)

13.30-15.30

General Session

Speaker slots are available for Cancer Diagnostics 2017

Coffee/Tea Break 10.40-10.55 (Networking)

Lunch Break 12.35-13.25

Mor

ning

Ses

sion

s

40 sp

eake

r for

day

309.00-10.40

Coffee/Tea Break 10.40-10.55 (Networking)10.55-12.35

Keynote speaker slots are available

Even

ing

Sess

ions Lunch Break 12.35-13.25

NOTE: Program Schedule is subject to change with final allotment of the speaker slots

Mor

ning

Ses

sion

sEv

enin

g Se

ssio

ns

Day 315.20-17.00

Day 2

40 sp

eake

r for

day

2

Coffee/Tea Break 15.05-15.20 (Networking)

13.25-15.05

Coffee/Tea Break 15.05-15.20 (Networking)15.20-17.00

5 Speakers (20 Mins Each)

09.00-10.40

Page 3: Cancer diagnostics 2017

Cancer Diagnostics 2017conferenceseries.com

http://cancerdiagnostics.conferenceseries.com/

Conference Highlights• Cancer Diagnostics Market

• Cancer Diagnostics Types

• Cancer Screening Tests

• Organ Specific Cancer

• Approaches in Cancer

Therapy

• Cancer Treatment and

Therapies

• Cancer BIomakers

• Cancer Immunotherapy

• Recent Diagnostics

Technologies

• Oncologists Meet

• Entrepreneurship Meet

For detailed sessions, please visit: http://cancerdiagnostics.conferenceseries.com/

Submit your abstract online at: http://cancerdiagnostics.conferenceseries.com/abstract-submission.php

Register online: http://cancerdiagnostics.conferenceseries.com/registration.php

Page 4: Cancer diagnostics 2017

Cancer Diagnostics 2017conferenceseries.com

http://cancerdiagnostics.conferenceseries.com/

Glimpses of Cancer Diagnostics 2016

Page 5: Cancer diagnostics 2017

Cancer Diagnostics 2017conferenceseries.com

http://cancerdiagnostics.conferenceseries.com/

Glimpses of Cancer Diagnostics 2016

Page 6: Cancer diagnostics 2017

Cancer Diagnostics 2017conferenceseries.com

http://cancerdiagnostics.conferenceseries.com/

Plan your Trip to Spain

Page 8: Cancer diagnostics 2017

June 13-15, 2016 Rome, ItalyCancer Diagnostics Conference & Expo

Scientific Programconferenceseries.com

Hosting Organization: Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-702-508-5200 Ext: 8047, Toll free: +1-800-216-6499

e-mail: [email protected]; [email protected]

Page 9: Cancer diagnostics 2017

Registrations

Opening Ceremony

Day 1 June 13, 2016

Group PhotoNetworking & Refreshments Break@ Foyer

Track 1: Cancer Diagnostics MarketTrack 2: Cancer Diagnostics Types

Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Tibor Tot, Central Hospital Falun, Sweden Title: Fast Evaluation of Biopsy for Prostate Cancer Diagnosis by Fraunhofer IKTSAndreas Lehmann, Fraunhofer Institute for Ceramic Technologies and Systems IKTS, GermanyTitle: How to develop a cancer diagnostic device for the POC settingJuan Roman, Cambridge Consultants, UKTitle: Engineering design process and comparison of multi wavelength real time auto-fluorescence and fluorescence imaging guide system irradiance with xenon lamps and light-emitting diodes (LEDs) for open and laparoscopic cancer surgeryHyun Soo lim, Chungnam National University, South KoreaTitle: Development of female vaginal fluid collection device for the endometrial cancer preliminary studyJhih-Yan Cheng, National Tsing Hua University, Taiwan

Lunch Break @ RestaurantTrack 7: Predictive Cancer Biomarkers Track 9: Cancer Treatment

Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Tibor Tot, Central Hospital Falun, Sweden Title: The role of pancreatic stellate cells in pancreatic disordersOleg V Gerasimenko, Cardiff University, UKTitle: Differences of signalling pathways and miRNA expression in colon and breast carcinoma cell lines on hipoxic conditionHafize Seda Vatansever, Celal Bayar University, TurkeyTitle: The role of Epo/EpoR signaling pathway in colorectal cancerRenata Dobrila Dintinjana, Clinical Hospital Center Rijeka, CroatiaTitle:Fertility sparing surgery in early stages of cervical cancer Aleksandar Stefanović, President M.D. Ph. D UGOSCGRS, BelgradeTitle: Fertility sparing in young patients with early stages of endometrial cancer Katarina Jeremic, University of Belgrade School of Medicine, Serbia

Networking & Refreshments Break@ Foyer

Olimpica-4conferenceseries.com

Keynote Forum

Scientific Program

Introduction

Title: Sensitivity and Specificity of the Empirical Lymphocyte Genome Sensitivity (LGS) Assay: Implications for Improving Cancer DiagnosticsDiana Anderson, University of Bradford, UKTitle: Optimal Breast Cancer Pathology 2016Tibor Tot, Centarl Hospital Falun, Sweden

Page 10: Cancer diagnostics 2017

Title: Anticancer activities of religiously important plants from IndiaRachana, Jaypee Institue of Information Technology, IndiaTitle: Prostatic tissue levels of chemical elements as cancer markersVladimir Zaichick, Medical Radiological Research Center, Russia

Special SessionTitle: Breast Cancer HeterogenityTibor Tot, Central Hospital Falun, Sweden Title: General Overview of the Comet assayDiana Anderson, University of Bradford, UK

Day 2 June 14, 2016Olimpica-4

Keynote Talk

Title: The UHRF1 expression in serum and tissue for gastric cancer detectionFeng Yan, Nanjing Medical University and Jiangsu Cancer Hospital, China

Track 3: Cancer Screening TestsTrack 6: Approaches in Cancer TherapyTrack 8: Cancer Genomics and EpigeneticsTrack 10: Recent Diagnostics Technologies

Session IntroductionSession Chair: Feng yan, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaSession Co-Chair: Senqing Chen, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaTitle: Serum biomarkers and ovarian cancer risk: Utility for early detection and preventionDayan Goodenowe, President, Phenomenome Discoveries Inc., CanadaTitle: Molecular basis of hereditary colorectal cancer and current research statusChen Senqing, Jiangsu Institute of Cancer Research, China

Networking & Refreshments Break@ FoyerTitle: The mechanisms of asparaginase-induced pancreatitisJulia V Gerasimenko, Cardiff University, UKTitle: Tumor-derived exosomes in cancer progression and treatment failureShaorong Yu, Jiangsu Institute of Cancer Research, ChinaTitle: Mast cells inhibition as therapeutic approach on mammary cancerAna I Faustino-Rocha, University of Trás-os-Montes and Alto Douro, Portugal

Poster PresentationsCDE001 Title: Prognostic significance of N-glycolyl GM3 ganglioside expression in non-small cell

lung carcinoma patients: New evidencesAdriana Carr Perez, Center of Molecular Immunology, Cuba

CDE002 Title: A functional approach for searching biomarkers of gliomaKopylov Alexey, Lomonosov Moscow State University, Russia

CDE003 Title: Molecular study of synthesis of protoporphyrin IX in fluoropositive and fluoronegative cell cultures of human glioblastomaPavlova Galina, Institute of Gene Biology-RAS, Russia

CDE004 Title: Renal cell carcinoma in kidney transplant candidatesKonstantinos A Zorbas, Temple University Hospital, USA

CDE005 Title: Frequent ID4 gene promoter hypermethylation in breast cancerYan Zhang, Jiangsu Cancer Hospital, China

CDE006 Title: Asymmetrical asymptomatic tonsilsJoseph Colclough, Northwick Park Hospital, UK

CDE007 Title: New ruthenium phthalocyanines in modulation of nitric oxide and singlet oxygen release: Physical chemical characterizations and improvement of cytotoxicity with liposomes against cancer cellsRamos L.C.B, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Brazil

CDE008 Title: The role of FABP9 in prostate cancerMajed Al Fayi, Liverpool University, UK

CDE009 Title: Experimental treatment of prostate cancer by suppressing the biological activity of FABP5Waseem Al-Jameel, University of Liverpool, UK

CDE010 Title: Improving Breast Cancer diagnosis by circulating microRNAs Julia Alejandra Pezuk, Instituto Sirio-Libanes de Ensino e Pesquisa – Hospital Sirio-Libanes- Sao Pablo, Brazil

Page 11: Cancer diagnostics 2017

Lunch Break@ RestaurantTitle: Comparison of the MRI sequences in ideal fiducial marker-based radiotherapy for prostate cancerOsamu Tanaka, Gifu Municipal Hospital, JapanTitle: Monitoring cancer progression by detecting circulating cancer cells with both epithelial and mesenchymal featuresYong-Jie Lu, Queen Mary University of London, London, UKTitle: The status of medicinal plants and herbal drugs in prevention and treatment of cancerMajid Asadi-Samani, Shahrekord University of Medical Sciences, IranTitle: Probable non-papillomavirus etiology of warty carcinoma of the uterine cervixDimitrova B, Medical University Pleven, BulgariaTitle: The possible involvement of Epstein–Barr virus in the etiology of leukemia in Sudanese patientsHaitham Eltigani Mohammed Elawad, Omdurman Islamic University, Sudan

Networking & Refreshments Break@ FoyerTitle: Combination Therapy against NGcGM3 ganglioside and EGFR: A new approach for lung cancer treatment.Adriana Carr Perez, Center of Molecular Immunology,CubaTitle: Evaluation of the SYT-SSX2 fusion gene transcript in synovial sarcoma cells and microvesicles as a potential biomarker for synovial sarcomaFricke Alba, University of Freiburg, Germany

Panel DiscussionsAward & Closing Ceremony

Day 3 June 15, 2016Networking and Lunch @ @ Restaurant

Conference Series2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA

Ph: +1-888-843-8169Fax: +1-650-618-1417

[email protected]

Conference Series5716 Corsa Ave., Suite 110, Westlake

Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414

[email protected]

Conference SeriesSEZ Unit, Building No. 20, 9th Floor

APIIC Layout, HiTec CityHyderabad-500081, Telangana, INDIA

Ph: 040-40131823, [email protected]

Toll freeUSA & Canada: +1-800-216-6499

Australia: +1-800-651-097Europe: 0805-080048